Already a member? Become a member Register
PCSK9 Forum

rss LinkedIn News
rss LinkedIn Latest News Updates

13th Closed Virtual Expert Meeting of the Editorial Board

1st and 8th October 2020

LDL-cholesterol: “The times are a-changin”

LDL-cholesterol: “The times are a-changin”

Reports from the 13th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Prof Alan Remaley 

read more »
Keynote – Lipoprotein(a): “The proof of the pudding is in the trial”

Keynote – Lipoprotein(a): “The proof of the pudding is in the trial”

Reports from the 13th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Joe Witztum 

read more »
Cost-effectiveness of PCSK9 inhibitors: A coming of age?

Cost-effectiveness of PCSK9 inhibitors: A coming of age?

Reports from the 13th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Dr. Kirsten Bibbins-Domingo & Prof. Dhruv S. Kazi 

read more »
A target level for LDL-C in secondary prevention: What have we learned from PCSK9 inhibitor trials?

A target level for LDL-C in secondary prevention: What have we learned from PCSK9 inhibitor trials?

Reports from the 13th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Gregory Schwartz 

read more »
LDL subclasses, bioactive lipids and atherogenicity: Impact of statin action

LDL subclasses, bioactive lipids and atherogenicity: Impact of statin action

Reports from the 13th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor John Chapman 

read more »
COVID-19 infection and cardiovascular events

COVID-19 infection and cardiovascular events

Reports from the 13th Closed Virtual Expert Meeting of the PCSK9 Education and Research Forum Professor Gilles Montalescot 

read more »